$RLMD
Relmada Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.23
▲+1.89%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRelmada Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RLMD up today? It is at $3.23 (+0.00%), and our scanner flagged it 64 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RLMD spikes, and full due diligence on RLMD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RLMD 64 times in the last 30 days. Create a free account to track $RLMD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RLMD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLMD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Traversa Sergio Officer | Bought (open market) | +100K 0.09% of company | added 7.1% | 1.50M | $410K at $4.10 | Sep 10, 26 |
Shenouda Maged Officer | Bought (open market) | +80K 0.07% of company | added 8.7% | 1.00M | $339K at $4.25 | Sep 10, 26 |
Traversa Sergio Officer | Bought (open market) | +100K 0.09% of company | added 7.7% | 1.40M | $418K at $4.18 | Sep 9, 26 |
Shenouda Maged Officer | Bought (open market) | +120K 0.1% of company | added 15% | 920K | $505K at $4.20 | Sep 9, 26 |
Shenouda Maged Officer | Bought (open market) | +12K 0.01% of company | added 1.5% | 800K | $48K at $4.12 | Dec 15, 25 |
Traversa Sergio Officer | Bought (open market) | +28K 0.03% of company | added 2.2% | 1.30M | $113K at $4.12 | Dec 15, 25 |
Shenouda Maged Officer | Bought (open market) | +500K 0.5% of company | added 100% | 788K | $1.1M at $2.20 | Nov 5, 25 |
Kelly Paul Edward Officer | Bought (open market) | +90K 0.08% of company | added 22% | 502K | $198K at $2.20 | Nov 5, 25 |
Traversa Sergio Officer | Bought (open market) | +273K 0.3% of company | added 27% | 1.27M | $600K at $2.20 | Nov 5, 25 |
Ence Chuck Officer | Bought (open market) | +136K 0.1% of company | added 51% | 404K | $299K at $2.20 | Nov 5, 25 |
Traversa Sergio Officer | Bought (open market) | +56K 0.05% of company | added 5.9% | 1.00M | $41K at $0.740 | Aug 28, 25 |
Traversa Sergio Officer | Bought (open market) | +129K 0.1% of company | added 16% | 944K | $87K at $0.670 | Aug 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RLMD from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLMD today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RLMD last traded at $3.23, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Relmada Therapeutics, Inc. Common Stock (RLMD) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RLMD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLMD 64 times in the last 30 days.
RLMD (Relmada Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $338M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLMD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RLMD discussion
Sign in to ask a question or join the discussion.